Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Cyclists to Ride from Chicago to Washington, D.C., to Raise Awareness for MSA and Funds for The Multiple System Atrophy Coalition
  • USA - English


News provided by

The MSA Coalition

May 20, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Make Your Mark: MSA Awareness Tour 2014
Make Your Mark: MSA Awareness Tour 2014

Chicago, IL (PRWEB) May 20, 2014 -- Two cyclists will ride more than 850 miles this summer to raise awareness of multiple system atrophy (MSA), a rare neurological disease that took the life of a loved one.

Neil Versel and Malcolm Versel will bike from Neil's home in Chicago to Washington, D.C., in memory of their father and brother, respectively. Mark Versel, of suburban Washington, died in May 2012 at age 68 due to MSA. To honor Mark, the tour is being called Make Your Mark: MSA Awareness Tour 2014.

Neil and Malcolm have planned a very grueling itinerary, symbolic of the difficult journey that Mark Versel faced during his illness with multiple system atrophy. We wish them lots of luck and look forward to following their progress in July.

Post this

Along the way, Neil and Malcolm will stop in the home towns of other families touched by MSA, which has no known cause, no effective treatments and is always fatal. The Versels will be spreading the message about this terrible disease, as well as raising money for The Multiple System Atrophy Coalition and related MSA organizations.

Make Your Mark: MSA Awareness Tour 2014 will begin on Friday, July 4, 2014 along Chicago's lakefront, and will conclude Monday, July 14, 2014, at the United States Capitol. Other riders are welcome to join for the first leg, 46 miles to Hobart, Ind., in exchange for a minimum $25 donation to The MSA Coalition. Riders also are invited to ride the final two legs, from Hagerstown, Md., to Rockville, Md. (58 miles), on Sunday, July 13, and 23 miles from Rockville to Capitol Hill in Washington the following day, in exchange for a donation.

"The MSA Coalition is very excited to support this tour," says Judy Biedenharn, President. "Multiple system atrophy is largely unknown to the general public, so this event will make a big impact in generating greater awareness. Neil and Malcolm have planned a very grueling itinerary, symbolic of the difficult journey that Mark Versel faced during his illness. We wish them lots of luck and look forward to following their progress in July.”

Dysautonomia International, a group dedicated to assisting people living with disorders of the autonomic nervous system — including MSA — will be hosting Dysautonomia Lobby Day on Capitol Hill Monday, July 14. Dysautonomia Lobby Day participants will be meeting with members of Congress to seek increased federal funding for research into MSA and other forms of dysautonomia, as well as insurance reimbursement for autonomic testing, which has become a problem with some insurers since last year.

Dysautonomia International President Lauren Stiles, Esq., notes, "We are delighted to have members of The MSA Coalition with us on Capitol Hill again this year. Individually, the different types of dysautonomia may be rare, but collectively, they are not rare at all. When we work together to have our message heard in Washington, it benefits everyone."
Events are being planned for July 5 in Kokomo, Ind., July 7 in Kettering, Ohio, July 8 in Columbus, Ohio, July 10 in St. Clairsville, Ohio, and July 13 in Rockville, Md. All are home to families affected by MSA.

The riders are currently looking for sponsors to defray the costs of the tour and raise additional funds for MSA research and support. Sponsors may have their logos displayed on rider jerseys, tour T-shirts, a rider support vehicle or at local events.
For more information about the cycling tour, please visit http://MSAtour.net and "like" our Facebook page at https://www.facebook.com/MakeYourMarkforMSA.

For more information about MSA or to donate to The Multiple System Atrophy Coalition, please visit http://www.Multiple-System-Atrophy.org. For more information about Dysautonomia International, please visit http://www.dysautonomiainternational.org.

The full itinerary is as follows, subject to change due to weather or road conditions:

Day 1, July 4: Chicago to Valparaiso, Ind. (62 miles), with a stop at an Independence Day celebration in Hobart, Ind., at mile 46.

Day 2, July 5: Valparaiso to Kokomo, Ind., home of several families affected by MSA (98 miles).

Day 3, July 6: Kokomo to Celina, Ohio (95 miles)

Day 4, July 7: Celina to Kettering, Ohio, home of MSA activists Frank and Susan Cervone (84 miles).

Day 5, July 8: Kettering to Columbus, Ohio, home of several families affected by MSA (85 miles).

Day 6, July 9: Columbus to Cambridge, Ohio (84 miles)

Day 7, July 10: Cambridge to Waynesburg, Pa. (102 miles), with a visit to an MSA-affected family in St. Clairsville, Ohio, at mile 46.

Day 8, July 11: Waynesburg to Grantsville, Md. (82 miles)

Day 9, July 12: Grantsville to Hagerstown, Md. (98 miles)

Day 10, July 13: Hagerstown to Rockville, Md. (58 miles).

Others are encouraged to ride this leg, or join in Frederick, Md., for the final 30 miles.
Day 11, July 14: Rockville to Capitol Hill, Washington, D.C. (23 miles) for Dysautonomia Lobby Day.

About Multiple System Atrophy
Multiple system atrophy (previously known as Shy-Drager Syndrome) is a rare and fatal disorder with less than 15,000 Americans diagnosed and 35,000 undiagnosed at any given time. According to the National Institutes of Health, "Multiple system atrophy is a progressive neurodegenerative disorder characterized by symptoms of autonomic nervous system failure such as fainting spells and bladder control problems (neurogenic orthostatic hypotension), combined with motor control symptoms such as tremor, rigidity and loss of muscle coordination. MSA affects both men and women primarily in their 50s. MSA tends to advance rapidly over the course of nine to 10 years, with progressive loss of motor skills, eventual confinement to bed, and death. There is no remission from the disease. Currently no cure is available."

About the Multiple System Atrophy Coalition
The Multiple System Atrophy Coalition is a positive beacon of hope standing up to a little known, rare, insidious disorder. Made up of dedicated volunteers, The MSA Coalition has a primary purpose of encouraging and funding research to find a cure. The Coalition also provides much needed patient and caregiver support, educational resources, and advocacy to create awareness and to fight for issues important to the MSA community. For more information or to donate to The Multiple System Atrophy Coalition, please visit: http://www.Multiple-System-Atrophy.org.

Don Crouse, The MSA Coalition, http://www.multiple-system-atrophy.org, +1 (866) 737-5999 Ext: 203, [email protected]

Modal title

The MSA Coalition Brochure
View PDF
The MSA Coalition Brochure
The MSA Coalition Brochure

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.